Atlas Trials

Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed

Clinical trial NCT01350609 · COMPLETED

Trial details

NCT number
NCT01350609
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension, Essential
Start date
2011-04-01
Primary completion
2011-08-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.